Literature DB >> 10516149

Divergent regulation of human and rat proglucagon gene promoters in vivo.

M Nian1, D J Drucker, D Irwin.   

Abstract

A single mammalian proglucagon gene is expressed in the brain, islets, and intestinal enteroendocrine cells, which gives rise to a unique profile of proglucagon-derived peptides (PGDPs) in each tissue. The biological importance of glucagon, glucagon-like peptide (GLP)-1, and GLP-2 has engendered considerable interest in the factors regulating the synthesis and secretion of the PGDPs in vivo. Although rat proglucagon gene transcription has been extensively studied, the factors important for control of human proglucagon gene expression have not been examined. We now report that, despite conservation of proximal promoter G1-G4 enhancer-like elements, human proglucagon reporter plasmids containing these elements are transcriptionally inactive in islet cell lines. Remarkably, larger human proglucagon promoter fragments, such as the 1604 hGLU-Luc, are expressed in GLUTag enteroendocrine cells but not in islet cell lines. A total of 5775 bases of human proglucagon promoter were required for expression in islet cell lines. Analysis of human proglucagon promoter expression in transgenic mice demonstrated that approximately 1.6 kb of human proglucagon gene sequences directs expression of a human growth hormone reporter gene to the brain and intestinal enteroendocrine cells but not islet cells in vivo. These findings provide the first evidence demonstrating divergence in the mechanisms utilized for tissue-specific regulation of the human and rodent proglucagon genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516149     DOI: 10.1152/ajpgi.1999.277.4.G829

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Direct regulation of the proglucagon gene by insulin, leptin, and cAMP in embryonic versus adult hypothalamic neurons.

Authors:  Prasad S Dalvi; Frederick D Erbiceanu; David M Irwin; Denise D Belsham
Journal:  Mol Endocrinol       Date:  2012-06-05

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

3.  Characterization of a novel Foxa (hepatocyte nuclear factor-3) site in the glucagon promoter that is conserved between rodents and humans.

Authors:  Sanjeev K Sharma; Ulrike Leinemann; Regine Ratke; Elke Oetjen; Roland Blume; Corinna Dickel; Willhart Knepel
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

Review 4.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

5.  Research Resource: Genetic Labeling of Human Islet Alpha Cells.

Authors:  Philip T Pauerstein; Keon Min Park; Heshan S Peiris; Jing Wang; Seung K Kim
Journal:  Mol Endocrinol       Date:  2016-01-08

Review 6.  Glucagon-Like Peptide-1: Actions and Influence on Pancreatic Hormone Function.

Authors:  Ellen M Davis; Darleen A Sandoval
Journal:  Compr Physiol       Date:  2020-03-12       Impact factor: 8.915

7.  Fluorescent protein vectors for pancreatic islet cell identification in live-cell imaging.

Authors:  Hongyan Shuai; Yunjian Xu; Qian Yu; Erik Gylfe; Anders Tengholm
Journal:  Pflugers Arch       Date:  2016-08-18       Impact factor: 3.657

Review 8.  Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity.

Authors:  Nicola Marrano; Giuseppina Biondi; Anna Borrelli; Angelo Cignarelli; Sebastio Perrini; Luigi Laviola; Francesco Giorgino; Annalisa Natalicchio
Journal:  Biomolecules       Date:  2021-02-15

Review 9.  GLP-1 and Underlying Beneficial Actions in Alzheimer's Disease, Hypertension, and NASH.

Authors:  Qiu-Xuan Li; Han Gao; Yue-Xin Guo; Bo-Ya Wang; Rong-Xuan Hua; Lei Gao; Hong-Wei Shang; Xin Lu; Jing-Dong Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-06       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.